143 related articles for article (PubMed ID: 30939113)
1. Drug S-oxidation and phenylalanine hydroxylase: a biomarker for neurodegenerative susceptibility in Parkinson's disease and amyotrophic lateral sclerosis.
Rawlings L; Turton L; Mitchell SC; Steventon GB
Drug Metab Pers Ther; 2019 Apr; 34(2):. PubMed ID: 30939113
[TBL] [Abstract][Full Text] [Related]
2. Phenylalanine hydroxylase: A biomarker of disease susceptibility in Parkinson's disease and Amyotrophic lateral sclerosis.
Steventon GB; Mitchell SC
Med Hypotheses; 2018 Sep; 118():29-33. PubMed ID: 30037610
[TBL] [Abstract][Full Text] [Related]
3. Phenylalanine 4-monooxygenase and the role of endobiotic metabolism enzymes in xenobiotic biotransformation.
Steventon GB; Mitchell SC
Expert Opin Drug Metab Toxicol; 2009 Oct; 5(10):1213-21. PubMed ID: 19653802
[TBL] [Abstract][Full Text] [Related]
4. An investigation into the inter-relationships of sulphur xeno-biotransformation pathways in Parkinson's and motor neurone diseases.
Steventon GB; Waring RH; Williams AC
Drug Metabol Drug Interact; 2003; 19(4):223-40. PubMed ID: 14768972
[TBL] [Abstract][Full Text] [Related]
5. Phenylalanine hydroxylase: possible involvement in the S-oxidation of S-carboxymethyl-l-cysteine.
Boonyapiwat B; Forbes B; Steventon GB
Anal Biochem; 2004 Dec; 335(1):91-7. PubMed ID: 15519575
[TBL] [Abstract][Full Text] [Related]
6. Phenylalanine 4-monooxygenase and the S-oxidation of S-carboxymethyl-L-cysteine.
Goreish AH; Bednar S; Jones H; Mitchell SC; Steventon GB
Drug Metabol Drug Interact; 2004; 20(3):159-74. PubMed ID: 15508431
[TBL] [Abstract][Full Text] [Related]
7. Phenylalanine 4-monooxygenase: the "sulfoxidation polymorphism".
Mitchell SC; Steventon GB
Xenobiotica; 2020 Jan; 50(1):51-63. PubMed ID: 31233370
[TBL] [Abstract][Full Text] [Related]
8. Metabolic Biomarkers and Neurodegeneration: A Pathway Enrichment Analysis of Alzheimer's Disease, Parkinson's Disease, and Amyotrophic Lateral Sclerosis.
Kori M; Aydın B; Unal S; Arga KY; Kazan D
OMICS; 2016 Nov; 20(11):645-661. PubMed ID: 27828769
[TBL] [Abstract][Full Text] [Related]
9. The S-oxidation of S-carboxymethyl-L-cysteine in hepatic cytosolic fractions from BTBR and phenylketonuria enu1 and enu2 mice.
Steventon GB; Mitchell SC
Xenobiotica; 2019 Apr; 49(4):495-502. PubMed ID: 29648495
[TBL] [Abstract][Full Text] [Related]
10. Phenylalanine 4-monooxygenase and the S-oxidation of S-carboxymethyl-L-cysteine by human cytosolic fractions.
Boonyapiwat B; Forbes B; Mitchell S; Steventon GB
Drug Metabol Drug Interact; 2008; 23(3-4):261-82. PubMed ID: 19326770
[TBL] [Abstract][Full Text] [Related]
11. The activity of wild type and mutant phenylalanine hydroxylase with respect to the C-oxidation of phenylalanine and the S-oxidation of S-carboxymethyl-L-cysteine.
Steventon GB; Mitchell SC; Pérez B; Desviat LR; Ugarte M
Mol Genet Metab; 2009 Jan; 96(1):27-31. PubMed ID: 19036622
[TBL] [Abstract][Full Text] [Related]
12. Biomarkers in Neurodegenerative Diseases.
Jeromin A; Bowser R
Adv Neurobiol; 2017; 15():491-528. PubMed ID: 28674995
[TBL] [Abstract][Full Text] [Related]
13. Can Oxidation-Reduction Potential of Cerebrospinal Fluid Be a Monitoring Biomarker in Amyotrophic Lateral Sclerosis?
Opačić M; Stević Z; Baščarević V; Živić M; Spasić M; Spasojević I
Antioxid Redox Signal; 2018 Jun; 28(17):1570-1575. PubMed ID: 29113448
[TBL] [Abstract][Full Text] [Related]
14. Recombinant heteromeric phenylalanine monooxygenase and the oxygenation of carbon and sulfur substrates.
Boonyapiwat B; Mitchell SC; Steventon GB
J Pharm Pharmacol; 2011 Apr; 63(4):558-64. PubMed ID: 21401608
[TBL] [Abstract][Full Text] [Related]
15. DJ-1 as a Biomarker of Parkinson's Disease.
Saito Y
Adv Exp Med Biol; 2017; 1037():149-171. PubMed ID: 29147908
[TBL] [Abstract][Full Text] [Related]
16. Distribution of arsenic, manganese, and selenium in the human brain in chronic renal insufficiency, Parkinson's disease, and amyotrophic lateral sclerosis.
Larsen NA; Pakkenberg H; Damsgaard E; Heydorn K; Wold S
J Neurol Sci; 1981 Sep; 51(3):437-46. PubMed ID: 7276987
[TBL] [Abstract][Full Text] [Related]
17. [Roles of exosomes in Parkinson's disease and amyotrophic lateral sclerosis].
Gu X; Chen Y; Shang H
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2018 Oct; 35(5):757-761. PubMed ID: 30298513
[TBL] [Abstract][Full Text] [Related]
18. Debrisoquine hydroxylase gene polymorphism in Parkinson's disease and amyotrophic lateral sclerosis.
Ray-Chaudhuri K; Smith C; Gough AC; Novak N; Chamoun V; Wolf CR; Leigh PN
J Neurol Neurosurg Psychiatry; 1995 Jan; 58(1):109. PubMed ID: 7823053
[No Abstract] [Full Text] [Related]
19. [Clinical significance of oxidation and acetylation genetic polymorphism in patients with Parkinson's disease].
Milejski P; Orzechowska-Juzwenko K; Kamienowski J; Horoch E; Niewiński P; Hurkacz M; Rzemisławska Z
Neurol Neurochir Pol; 1999; 33(5):1015-24. PubMed ID: 10672554
[TBL] [Abstract][Full Text] [Related]
20. Protein disulphide isomerase protects against protein aggregation and is S-nitrosylated in amyotrophic lateral sclerosis.
Walker AK; Farg MA; Bye CR; McLean CA; Horne MK; Atkin JD
Brain; 2010 Jan; 133(Pt 1):105-16. PubMed ID: 19903735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
